ARCHIVES

Slow Accruing Trials Should Be Removed From High Priority Program, Broder Says

This article is from The Cancer Letter archive.

Vol. 18 No. 38 | October 2, 1992

Download PDF Visit The Full Archive

Related Articles

Two Reports Offer Definitions, Plans For Comparative Effectiveness Research

July 3, 2009

NHLBI Advisers Commit Funding TO NCI’s Women’s Health Trials, Tamoxifen Trial

March 8, 1991

NCI Plans $30 Million In Patient-Oriented Chemoprevention research In Next 5 Years

December 6, 1996

NCAB Asks For Cost Reimbursement n Patients In Clinical Trials Until More Data Available

October 5, 1984

Solomon Garb’s Questions/Answers

December 19, 1980

Program Announcements For Tobacco Research

January 21, 1983